These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 693562)

  • 1. Tetrahydrocannabinol and acetylcholinesterase.
    Moss DE; Peck PL; Salome R
    Pharmacol Biochem Behav; 1978 Jun; 8(6):763-5. PubMed ID: 693562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of physostigmine and delta-9-tetrahydrocannabinol in man.
    Freemon FR; Rosenblatt JE; EL-Yousef MK
    Clin Pharmacol Ther; 1975 Feb; 17(2):121-6. PubMed ID: 1091392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
    Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M
    Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effects of Δ
    Gholami D; Noori AR; Mohammadkhani M; Emruzi Z; Riazi GH
    Arch Biochem Biophys; 2020 Oct; 693():108574. PubMed ID: 32898566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
    J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in rat adrenal medulla following delta9-tetrahydrocannabinol treatment. A histochemical study.
    Biswas B; Deb G; Ghosh JJ
    Acta Endocrinol (Copenh); 1975 Oct; 80(2):329-38. PubMed ID: 126628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydrocannabinol potentiates reserpine-induced hypokinesia.
    Moss DE; McMaster SB; Rogers J
    Pharmacol Biochem Behav; 1981 Nov; 15(5):779-83. PubMed ID: 6273940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats.
    Corchero J; García-Gil L; Manzanares J; Fernández-Ruiz JJ; Fuentes JA; Ramos JA
    Life Sci; 1998; 63(10):843-50. PubMed ID: 9734704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.
    Hayakawa K; Mishima K; Nozako M; Hazekawa M; Ogata A; Fujioka M; Harada K; Mishima S; Orito K; Egashira N; Iwasaki K; Fujiwara M
    Life Sci; 2007 Mar; 80(16):1466-71. PubMed ID: 17289082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
    Shen M; Thayer SA
    Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
    Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
    J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
    Green K; Kearse EC; McIntyre OL
    Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular link between the active component of marijuana and Alzheimer's disease pathology.
    Eubanks LM; Rogers CJ; Beuscher AE; Koob GF; Olson AJ; Dickerson TJ; Janda KD
    Mol Pharm; 2006; 3(6):773-7. PubMed ID: 17140265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
    Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
    Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
    Hillard CJ; Bloom AS; Houslay MD
    Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of delta9-tetrahydrocannabinol on mitochondrial NADH-oxidase activity.
    Bartova A; Birmingham MK
    J Biol Chem; 1976 Aug; 251(16):5002-6. PubMed ID: 956173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats.
    Irimia C; Polis IY; Stouffer D; Parsons LH
    Psychopharmacology (Berl); 2015 Aug; 232(16):3033-43. PubMed ID: 25925779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.